Net revenue rose 13% in H1 2024, driven by student base growth and higher average ticket. Adjusted EBITDA and net earnings increased, with strong free cash generation and expanded medical school capacity via FAPI acquisition. Digital transformation and operational efficiencies continue to support growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.